Recently, a novel drug ALT001 was developed and shown to improve cognitive impairment in mouse models of AD by inducing mitochondrial biogenesis and stimulating ULK1/Rab9-dependent mitophagy 20. Here, ULK1 is linked to Alzheimer disease.